Australian Clinical Labs Limited

Informe acción ASX:ACL

Capitalización de mercado: AU$682.4m

Australian Clinical Labs Dirección

Dirección controles de criterios 3/4

El CEO de Australian Clinical Labs es Melinda McGrath , nombrado en Dec 2020, tiene una permanencia de 3.92 años. compensación anual total es A$1.56M, compuesta por 55.9% salario y 44.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.09% de las acciones de la empresa, por valor de A$7.53M. La antigüedad media del equipo directivo y de la junta directiva es de 5.4 años y 3.6 años, respectivamente.

Información clave

Melinda McGrath

Chief Executive Officer (CEO)

AU$1.6m

Compensación total

Porcentaje del salario del CEO55.9%
Permanencia del CEO3.9yrs
Participación del CEO1.1%
Permanencia media de la dirección5.4yrs
Promedio de permanencia en la Junta Directiva3.6yrs

Actualizaciones recientes de la dirección

Recent updates

Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Sep 03
Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

Sep 02
Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Jun 20
We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Feb 21
Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Dec 08
Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Aug 14
Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 25
Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

Dec 22
New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

Dec 21
The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Sep 01
The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Melinda McGrath en comparación con los beneficios de Australian Clinical Labs?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024AU$2mAU$873k

AU$24m

Mar 31 2024n/an/a

AU$20m

Dec 31 2023n/an/a

AU$15m

Sep 30 2023n/an/a

AU$26m

Jun 30 2023AU$1mAU$873k

AU$36m

Mar 31 2023n/an/a

AU$55m

Dec 31 2022n/an/a

AU$73m

Sep 30 2022n/an/a

AU$126m

Jun 30 2022AU$2mAU$873k

AU$178m

Mar 31 2022n/an/a

AU$156m

Dec 31 2021n/an/a

AU$134m

Sep 30 2021n/an/a

AU$97m

Jun 30 2021AU$2mAU$875k

AU$60m

Mar 31 2021n/an/a

AU$79m

Dec 31 2020n/an/a

AU$98m

Sep 30 2020n/an/a

AU$70m

Jun 30 2020AU$2mAU$852k

AU$41m

Compensación vs. Mercado: La compensación total ($USD1.02M) de Melinda está en línea con el promedio de empresas de tamaño similar en el mercado Australian ($USD910.58K).

Compensación vs. Ingresos: La compensación de Melinda ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.

CEO

Melinda McGrath

3.9yrs

Permanencia

AU$1,560,335

Compensación

Ms. Melinda McGrath is Chief Executive Officer and Executive Director at Australian Clinical Labs Limited since December 19, 2020. She served as Chief Executive Officer and Executive Director at Clinical L...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Melinda McGrath
CEO & Executive Director3.9yrsAU$1.56m1.09%
A$ 7.4m
Darren McKee
Chief Executive Officer of Victoria1.8yrsAU$37.27ksin datos
Matthew Cordingley
Chief Financial Officerless than a yearsin datossin datos
Anthony Friedli
Chief Operating Officer8.8yrssin datos0%
A$ 0
Sean Jackson
Chief Information Officer9.8yrssin datossin datos
Joe Geran
National Marketing Directorno datasin datossin datos
Tony Landgren
National Medical Director & Chief Pathologist15.8yrssin datos0%
A$ 0
Chris Brownlow
Chief Executive Officer of New South Wales & Australian Capital Territory13.8yrssin datossin datos
Shae Seymour
Chief Executive Officer of WA/SA/NT6.8yrssin datossin datos
Eleanor Padman
Company Secretary3.6yrssin datossin datos
Rob Izzard
Chief Executive Officer of ACL Commercial Pathology1.8yrssin datossin datos

5.4yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de ACL es experimentado (5.4 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Melinda McGrath
CEO & Executive Director3.9yrsAU$1.56m1.09%
A$ 7.4m
Michael Alscher
Non-Executive Chairman1.2yrsAU$152.73k0.14%
A$ 958.1k
Christine Bartlett
Independent Non-Executive Director1.3yrsAU$111.74k0.010%
A$ 68.3k
Leanne Rowe
Independent Non-Executive Director3.6yrsAU$131.18k0.0025%
A$ 17.1k
Mark Haberlin
Independent Non-Executive Director3.6yrsAU$136.23k0.024%
A$ 162.3k

3.6yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de ACL se considera experimentada (3.6 años de antigüedad promedio).